Skip to main content

Marc Miravitlles Fernández

I’m a specialist in Respiratory Medicine trained at Vall d’Hebron Hospital in Barcelona. My focus is on clinical research in chronic obstructive pulmonary disease (COPD) and alpha-1 antitrypsin deficiency (AATD) with the objective to find a cure and improve the quality of life of patients suffering these chronic respiratory diseases.

Institutions of which they are part

Postdoctoral researcher
Pneumology
Vall Hebron Institut de Recerca
Doctor
Pneumology
General Hospital
I’m a Pulmonologist and Senior Researcher at the Vall d’Hebron University Hospital and the Vall d’Hebron Research Institute (VHIR) in Barcelona, Spain.
I obtained my MD at the Universitat de Barcelona, Barcelona, Spain in 1986 and my PhD at the Universitat Autònoma de Bacelona in 1997. I trained as specialist in Respiratory Medicine at Vall d'Hebron Hospital. My primary research interests include chronic obstructive pulmonary disease (COPD), alpha-1-antitrypsin deficiency (AAT), lung defence mechanisms and respiratory infections. I served as Secretary General of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) from 1999 to 2003 and I was responsible for International Relationships of SEPAR from 2006 until 2012. I was Chair of the Respiratory Infections Group of the European Respiratory Society (ERS) from 2008 to 2011 and I was the Guidelines Director of the ERS from 2015 to 2018.
I have acted as a consultant and/or chair or author for the development of different international guidelines of COPD, including the American Thoracic Society (ATS)/ERS task force on outcomes in COPD, the ERS/ATS guidelines on diagnostic and treatment of exacerbations of COPD and the ERS statement on management of alpha-1 antitrypsin deficiency. I am also a consultant of the Spanish Ministry of Health for the development of the National Strategy Against COPD (2009 to present) and coordinator of the Spanish National Guidelines for COPD (GesEPOC from 2012). I am the director of the reference center for diagnosis and treatment of AATD in the Hospital Vall d’Hebron and I am author of 498 publications listed in PubMed and a h-index of 73 (May 2020)

Projects

Caracterización y factores de riesgo de las SEcuelas PULmonares de los pacientes que superan una neumonía por COVID-19 (PULSE-COVID).

IP: Fco. Javier Muñoz Gall
Collaborators: Maria Angeles Jiménez Fuentes, Marc Miravitlles Fernández, David Clofent Alarcón, David Soler Segovia
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI21/01046
Duration: 01/01/2022 - 31/12/2024

"Biomarcadores sistémicos en pacientes con Asthma-COPD overlap (ACO)"

IP: Marc Miravitlles Fernández
Collaborators: -
Funding agency:
Funding:
Reference: PR(AG)44/2019
Duration: -

Dolor en pacientes con EPOC y su repercusión. Estudio DOLEPOC

IP: Marc Miravitlles Fernández
Collaborators: -
Funding agency:
Funding:
Reference: PR(AG)70/2019
Duration: -

Estudio de la actividad anti-elastasa en la EPOC y en el déficit de alfa-1 antitripsina.

IP: Marc Miravitlles Fernández
Collaborators: -
Funding agency:
Funding:
Reference: PR(AG)102/2019
Duration: -

Related news

The paper has shown that those patients who are not able to normalize their microbiome after surgery have a worse prognosis.

The two studies awarded has been the research for a the ciliary dyskinesia diagnosis led by the VHIR’s Growth and Development Group and the EPISCAN II, in which Dr. Miravitlles has participated.

Entre els projectes més rellevants en Covid-19 destaca la participació del VHIR en assaigs clínics per provar l’eficàcia i seguretat de vacunes com ara Janssen, Pfizer-BioNTech en el col·lectiu d’embarassades, i Hipra.

Related professionals

Sergi Martí Beltran

Sergi Martí Beltran

Pneumology
Read more
Victoria Ruiz De Miguel

Victoria Ruiz De Miguel

Predoctoral researcher
Pneumology
Read more
Sonia Lopez  Rodriguez

Sonia Lopez Rodriguez

Predoctoral researcher
Pneumology
Read more
Eva Polverino

Eva Polverino

Postdoctoral researcher
Pneumology
Read more

Subscriu-te als nostres butlletíns i forma part de la vida del Campus

El Vall d’Hebron Barcelona Hospital Campus és un parc sanitari de referència mundial on assistència, recerca, docència i innovació es donen la mà.